Locally Advanced Sarcoma
6 clinical trials · Condition
◉ Watch Locally Advanced Sarcoma
| Record | Firm | Date |
|---|---|---|
| Cemiplimab for Secondary Angiosarcomas (NCT04873375) | Radboud University Medical Center | 2022-01-01 |
| Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST) (NCT04595747) | National Cancer Institute (NCI) | 2021-05-03 |
| Rolapitant Hydrochloride in Preventing Nausea/Vomiting in Patients With Sarcoma Receiving Chemotherapy (NCT02732015) | M.D. Anderson Cancer Center | 2016-10-12 |
| Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants With Sarcoma (IMDZ-C232/V943A-002) (NCT02609984) | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2015-04-29 |
| Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas (NCT01106872) | Mohammed M Milhem | 2010-09-01 |
Track Locally Advanced Sarcoma automatically
Every clearance here is in the API, with alerts when new ones post.